Development and performance of a two-step desflurane-O(2)/N(2)O fresh gas flow sequence. 2008

Jan F A Hendrickx, and Bram B C Dewulf, and Nathalie De Mey, and Rik Carette, and Thierry Deloof, and Sofie De Cooman, and Andre M De Wolf
Department of Anesthesiology, Intensive Care and Pain Therapy, Onze Lieve Vrouw Hospital, Aalst, Belgium. jcnwahendrickx@yahoo.com

OBJECTIVE To determine if the previously described single-step O(2)/N(2)O fresh gas flow (FGF) sequence could be combined with a simple desflurane vaporizer (F(D)) sequence to maintain the end-expired desflurane (F(A)des) at 4.5% with the anesthesia delivery unit machine (ADU Anesthesia Machine(R); General Electric, Helsinki, Finland). METHODS Prospective randomized clinical study. METHODS Onze Lieve Vrouw Hospital, Aalst, Belgium, a large teaching hospital. METHODS 42 ASA physical status I and II patients requiring general endotracheal anesthesia and controlled mechanical ventilation. METHODS In 18 patients undergoing general anesthesia with controlled mechanical ventilation, F(D) was determined to maintain F(A)des at 4.5% with O(2)/N(2)O FGF of two and 4 L per minute for three minutes and 0.3 and 0.4 L per minute thereafter. Using the same FGF sequence, we prospectively tested the F(D) schedule that approached this observed F(D) pattern with the fewest possible adjustments in another 24 patients. RESULTS F(D) of 6.5% for 15 minutes followed by 5.5% thereafter approximated the observed F(D) course well. When it was prospectively tested, the median (25th, 75th percentiles) performance error was -1% (-5.1%, 5.2%); absolute performance error, 7.1% (3.9%, 9.5%); divergence, -6.6% per hour (23.1%, 3.1%/h); and wobble, 2.2% (1.8%, 3.2%). Because F(A)des increased above 4.9%, F(D) was decreased in 5 patients after 23 minutes (0.5% decrement once or twice); in two patients, F(D) was temporarily increased. In one patient, FGF was temporarily increased because the bellows volume became insufficient. CONCLUSIONS One O(2)/N(2)O rotameter FGF setting change from 6 to 0.7 L per minute after three minutes and one desflurane F(D) change from 6.5% to 5.5% after 15 minutes maintained anesthetic gas concentrations within predictable and clinically acceptable limits during the first 20 minutes.

UI MeSH Term Description Entries
D007530 Isoflurane A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009609 Nitrous Oxide Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream. Laughing Gas,Nitrogen Protoxide,Gas, Laughing,Oxide, Nitrous
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012119 Respiration The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration ( Breathing
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077335 Desflurane A fluorinated ether that is used as a volatile anesthetic for maintenance of general anesthesia. 1,2,2,2-Tetrafluoroethyl difluoromethyl ether,I 653,I-653,I653,Suprane

Related Publications

Jan F A Hendrickx, and Bram B C Dewulf, and Nathalie De Mey, and Rik Carette, and Thierry Deloof, and Sofie De Cooman, and Andre M De Wolf
November 2009, Anaesthesia and intensive care,
Jan F A Hendrickx, and Bram B C Dewulf, and Nathalie De Mey, and Rik Carette, and Thierry Deloof, and Sofie De Cooman, and Andre M De Wolf
December 2014, Korean journal of anesthesiology,
Jan F A Hendrickx, and Bram B C Dewulf, and Nathalie De Mey, and Rik Carette, and Thierry Deloof, and Sofie De Cooman, and Andre M De Wolf
February 2001, Anaesthesia,
Jan F A Hendrickx, and Bram B C Dewulf, and Nathalie De Mey, and Rik Carette, and Thierry Deloof, and Sofie De Cooman, and Andre M De Wolf
December 2014, The Journal of international medical research,
Jan F A Hendrickx, and Bram B C Dewulf, and Nathalie De Mey, and Rik Carette, and Thierry Deloof, and Sofie De Cooman, and Andre M De Wolf
May 2011, Anaesthesia and intensive care,
Jan F A Hendrickx, and Bram B C Dewulf, and Nathalie De Mey, and Rik Carette, and Thierry Deloof, and Sofie De Cooman, and Andre M De Wolf
August 2006, Der Anaesthesist,
Jan F A Hendrickx, and Bram B C Dewulf, and Nathalie De Mey, and Rik Carette, and Thierry Deloof, and Sofie De Cooman, and Andre M De Wolf
September 2001, Anaesthesia,
Jan F A Hendrickx, and Bram B C Dewulf, and Nathalie De Mey, and Rik Carette, and Thierry Deloof, and Sofie De Cooman, and Andre M De Wolf
April 2001, Anaesthesia,
Jan F A Hendrickx, and Bram B C Dewulf, and Nathalie De Mey, and Rik Carette, and Thierry Deloof, and Sofie De Cooman, and Andre M De Wolf
January 2017, F1000Research,
Jan F A Hendrickx, and Bram B C Dewulf, and Nathalie De Mey, and Rik Carette, and Thierry Deloof, and Sofie De Cooman, and Andre M De Wolf
March 1998, Anaesthesia,
Copied contents to your clipboard!